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Abstract
Background: To describe approaches used in systematic reviews of diagnostic test accuracy studies for assessing
variability in estimates of accuracy between studies and to provide guidance in this area.
Methods: Meta-analyses of diagnostic test accuracy studies published between May and September 2012 were
systematically identified. Information on how the variability in results was investigated was extracted.
Results: Of the 53 meta-analyses included in the review, most (n=48; 91 %) presented variability in diagnostic
accuracy estimates visually either through forest plots or ROC plots and the majority (n=40; 75 %) presented a test
or statistical measure for the variability. Twenty-eight reviews (53 %) tested for variability beyond chance
using Cochran’s Q test and 31 (58 %) reviews quantified it with I2. 7 reviews (13 %) presented between-study
variance estimates (τ2) from random effects models and 3 of these presented a prediction interval or ellipse
to facilitate interpretation. Half of all the meta-analyses specified what was considered a significant amount of
variability (n=24; 49 %).
Conclusions: Approaches to assessing variability in estimates of accuracy varied widely between diagnostic
test accuracy reviews and there is room for improvement. We provide initial guidance, complemented by an
overview of the currently available approaches.
Keywords: Meta-analysis, Diagnostic techniques and procedures/standards, Sensitivity and specificity, Data
interpretation, Statistical, Bias (epidemiology)
Background
Over the past decade, there has been a sharp increase in
the number of meta-analyses of diagnostic studies pub-
lished and the methods for performing such a meta-
analysis have rapidly evolved [1, 2]. Analyzing the variability
in results from primary studies is challenging in any type of
systematic review, but it is even more difficult in systematic
reviews of diagnostic studies. This is because the interest is
often in two correlated estimates from the same study: pairs
of sensitivity and specificity. How the variability in the re-
sults of diagnostic studies can best be assessed demands
further attention.
Estimates of test accuracy are likely to differ between
studies in a meta-analysis. This is referred to as
variability or heterogeneity (in the broad sense of the
word) [3]. Some variability in estimates can be expected
simply due to chance as a result of sampling error. Even
if studies are methodologically identical and carried out
in the same population, their results may differ because
each study only observes a sample from the entire theor-
etical population. When there is more variability than
expected due to chance alone, this is termed statistical
heterogeneity, and is referred to by some as “true het-
erogeneity” or simply as heterogeneity [4–6]. When
there is statistical heterogeneity, it indicates that a test’s
accuracy differs between studies (this is sometimes re-
ferred to as a difference in “true effects”). Review authors
may be encouraged to look into possible explanations
for these differences as they may have important clinical
implications [3, 5]. The more variability beyond chance
there is, the more difficult it is to come to strong* Correspondence: c.naaktgeboren@umcutrecht.nl1Julius Center for Health Sciences and Primary Care, University Medical
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conclusions about the clinical implications of the find-
ings of the meta-analysis [7].
When there is a single (univariate) measure of effect,
Cochran’s Q test is often used to test for variability be-
yond chance and I2 is used to quantify this variability.
Unlike reviews of interventions that focus on a single
measure of effect (e.g., a risk ratio or odds ratio), reviews
of diagnostic studies often meta-analyze two correlated
outcomes, namely sensitivity and specificity (the propor-
tions of diseased and non-diseased that are correctly
identified). Sensitivity and specificity vary inversely with
the threshold at which patients are considered diseased,
leading to a negative correlation between these estimates
known as the threshold effect. Thresholds can be expli-
cit, such as specific values used in laboratory tests, or
implicit, such as differences in the way that imaging tests
are interpreted between studies.
In a meta-analysis of diagnostic tests, the explicit or
implicit thresholds of the test under study may differ
across studies, leading to varying estimates of sensitivity
and specificity. It is clinically relevant to know about the
variability that exists beyond what could be attributed to
either chance or the threshold effect. Instead of perform-
ing two separate univariate analyses of sensitivity and
specificity in which it is impossible to calculate the
amount of variability that is due to the threshold effect,
another approach is to focus on a single parameter, such
as the diagnostic odds ratio (DOR), overall accuracy, or
the Youden’s index. The Moses-Littenberg summary re-
ceiver operating characteristic curve (SROC) takes this
approach by modeling the relationship between accuracy
and a parameter related to the threshold, namely, the
proportion with positive test results [8]. More recently,
however, it has been shown that hierarchical bivariate
random effects models are more appropriate and more
insightful, such as the bivariate random effects model
proposed by Reitsma et al., which focuses on estimating
a summary point and corresponding confidence region
or the Hierarchical SROC (HSROC) model, which fo-
cuses on fitting a summary receiver operating character-
istic (SROC) curve [9–11]. These models are both
random effects models which assume that the true ef-
fects vary with a given distribution around a mean value
and estimates that distribution, as opposed to fixed ef-
fect models which assume that all studies share the same
common effect. The HSROC and the bivariate model
are identical when no covariates are included and pa-
rameters from one model can be used to calculate those
from the other [12]. The bivariate random effects ana-
lysis estimates the amount of correlation between the
two outcome measures, thereby enabling the calculation
of the conditional between-study variances (i.e., the vari-
ance in specificity at a fixed value of sensitivity and vice
versa) that are smaller than the between-study variances
from two separate univariate analyses of sensitivity and
specificity in case there is a (negative) correlation be-
tween the two outcome measures.
The aim of this review is to survey which methods are
currently used to visualize, test, measure, interpret, and
inform readers about variability in results in meta-
analysis of diagnostic studies. This study is complemen-
tary to another review that we have done on how
sources of heterogeneity are explored [13]. In the discus-
sion we provide initial guidance on testing for and quan-
tifying variability in reviews of diagnostic test accuracy.
Methods
This study was a part of a meta-epidemiologic project
on systematic reviews of diagnostic studies. The goal of
this project was to investigate several methodological
topics such as publication bias, small sample size effects,
time lag bias, quality assessment, and how sources of
variability are explored. A database containing a set of
reviews of diagnostic tests was established for this
project.
Systematic reviews on diagnostic tests that were
indexed between May 1st and September 11th, 2012 were
identified on September 12th using a systematic search
in EMBASE and MEDLINE (Additional file 1). As this
article is about formal (statistical) methods for assessing
variability in study results, we focused on the systematic
reviews containing a meta-analysis. However, we add-
itionally examined the systematic reviews captured by
this search strategy in which no meta-analysis was per-
formed for the sole purpose of investigating whether
high variability in study results was a reason for not per-
forming a meta-analysis. A meta-analysis was defined as
a review in which a summary estimate for at least one
diagnostic accuracy estimator was reported or in which
a summary ROC curve (SROC) was provided. Reviews
on prognostic tests, individual patient data reviews, con-
ference abstracts, or written in a language other than
English were excluded.
Data extraction was performed using a standardized
form by one reviewer and the extraction was checked by
a second reviewer. For the overarching project, general
study characteristics of interest for all parts of the pro-
ject, such as the type of test under study and the number
of primary studies, were extracted from the reviews. For
this study, information was extracted on how the results
of the meta-analyses were presented graphically, which
statistical tests or measures for variability were used,
how the results of variability were used to guide the ana-
lysis, and how the variability in results was mentioned in
the discussion and/or conclusions.
To facilitate interpretation of our results, we have pro-
vided an explanation of the terminology, different mea-
sures and statistical tests that are used when
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investigating variability in univariate analyses, like
Cochran’s Q test, I2,τ2, and prediction intervals in
Additional file 2.
Results
Search results
The search resulted 1273 hits after duplicates were ex-
cluded. Title screening resulted in the elimination of
1058 articles. The full text of the remaining 89 poten-
tially relevant articles was read to determine whether ar-
ticles met the inclusion criteria. In the end, 65 reviews,
of which 53 contained a meta-analysis and 12 did not,
were included. Additional file 3 contains the study inclu-
sion flow chart and Additional file 4 contains a list of
the included systematic reviews.
General characteristics of the reviews
General characteristics of the 53 reviews that contained
a meta-analysis can be found in Table 1. Most meta-
analyses contained a low number of studies, with a
median of 14 (Interquartile range (IQR): 9.5–18.5). The
majority of reviews were on imaging tests (60 %), a large
percentage was on lab tests (26 %), and a few were on
clinical or physical examination procedures (14 %). Over
half of the meta-analyses studied the accuracy of more
than one test.
Of the 12 systematic reviews that did not perform a
meta-analysis, eight stated that they did not do so be-
cause there was too much clinical or methodological
heterogeneity between the studies. None of these 12
reviews reported that the amount of between-study vari-
ability in results was a reason not to perform a meta-
analysis. Other additional reasons given for not performing
a meta-analysis were low quality of the primary studies
(n=4), too few primary studies (n=2), and studies having
different cut-offs for defining a positive test result (n=1).
When obtaining summary estimates of test accuracy,
about a third of the reviews used a more advanced hier-
archical bivariate random effects model: 13 (25 %) used
a bivariate random effects model and 5 (9 %) used a
hierarchical summary ROC (HSROC) model [9, 10]. Al-
most half used the Moses-Littenberg summary ROC ap-
proach (n=24; 45 %) [8]. A quarter of the meta-analyses
only used a univariate approach, pooling results for the
summary estimates separately (n=13; 25 %).
Visual presentation of variability
The various approaches and measures to investigate and
report variability in results are summarized in Table 2.
The first step in assessing variability is typically to exam-
ine the study results visually, either through a forest plot
per accuracy measure or by plotting pairs of sensitivity
and specificity together in ROC space. Thirty-four of the
53 reviews with a meta-analysis (64 %) contained forest
plots for at least one accuracy measure. Even more pre-
sented results in an ROC plot (n=40; 75 %). Of these, ap-
proximately two-thirds (n=27) indicated the relative size
of the studies by varying the size of the points. Three re-
views went further to indicate the relative size of the dis-
eased and non-diseased group by varying the vertical
and horizontal size of the points. Five reviews (9 %) con-
tained neither a forest nor a ROC plot.
Testing for and quantifying statistical heterogeneity
The methods used for testing and quantifying hetero-
geneity per parameter can be found in Table 3.
Cochran’s Q test for statistical heterogeneity was used in
about half of the reviews (n=28; 53 %). The same was
true for the inconsistency index (I2) (n=31; 58 %). The
confidence interval for I2 was only provided in 7 of these
31 reviews. Cochran’s Q test and I2 were only used for
univariate analyses, in other words, only on one accuracy
measure at a time. Some reviews (also) used these met-
rics on an “overall measure” for accuracy such as the
DOR (Cochran’s Q test, n=9; I2, n=10) or percentage
total agreement (Cochran’s Q test, n=2; I2, n=2). Other
reviews used at least one of these metrics on likelihood
ratios (n=9) and/or predictive values (n=3).
About half of the articles described how they would
consider whether variation beyond chance was present or
relevant (n=24; 49 %). Of these, 10 based their conclusion
on the p-value from Cochran’s Q test, 7 looked at the I2,
and the remaining 7 relied on both. Reviews were classi-
fied as having used both statistics simultaneously when it
was unclear which one was used to draw conclusions. For
example, one study reported, “Heterogeneity was assessed
Table 1 Characteristics of meta-analyses included in the review
(n=53)
Characteristic N or median % or IQR
Median number of primary studies 14 [9.5–18.5]
Median number of patients in primary studies 87 [45–182]
Type of test tests under study
Laboratory tests 15 28 %
Image tests 32 60 %
Clinical examination 6 11 %
Meta-analyses looking at more than one test 31 58 %
Method(s) for conducting the meta-analysis†
Univariate analysis only 13 25 %
SROC (Moses Littenberg): linear regression
D on S
24 45 %
HSROC (Rutter and Gatsonis): accuracy, scale
and threshold parameter
5 9 %
Bivariate random effects model (Reitsma):
random effects sens & spec
13 25 %
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using the Q and I2 tests. The results were considered to
be significant when p<0.1 or I2> 50 %.” [14].
Of the 10 reviews which derived their conclusions only
from Cochran’s Q test, 8 considered there to be statis-
tical heterogeneity when the p-value was <0.05 while the
other 2 chose a less strict p-value of <0.1. For the 7 re-
views which based their conclusions only on I2, 4 pro-
vided ranges for what was considered low, medium, or
high variability. The ranges provided were different
amongst these 4 reviews. Three meta-analyses only
Table 2 Methods for presenting, testing, measuring, and communicating variability in results (n=53)
Method Number Percent
Graphical
Plots present in article
No plots 5 9 %
Forest Plots 34 64 %
ROC 40 75 %
Both 26 49 %
Statistical
Cochran’s Q test 28 53 %
I2 31 58 %
Confidence Intervals presented 7 13 %
τ2 7 13 %
From a univariate analysis 6 11 %
From a bivariate analysis 1 2 %
Prediction intervals, ellipses, or bands 3 6 %
Provided a definition for significant variability 24 49 %
Cochran’s Q test 10 19 %
I2 7 11 %
Cochran’s Q test or I2 7 13 %
Influence of variability on analysis approach (reported by authors)
Whether to perform a meta-analysis in the first placea 1a 4 %a
Whether to use a fixed or a random effects model 16 30 %
Whether to investigate sources of heterogeneity 4 8 %
How variability in results is mentioned in the abstract and discussion and/or conclusions Discussion/Conclusions Abstract
Any mention of variability listed below 29 (55 %) 15 (28 %)
A vague discussion variabilityb 17 (32 %) 10 (19 %)
Reported results of a statistical test or measurement of variability N/A 4 (8 %)
Variability in results precludes firm conclusions or is a study limitation 13 (25 %) 2 (4 %)
Despite variability in results, a conclusion could still be made 7 (13 %) 3 (6 %)
There was no relevant variability in results 1 (2 %) 2 (4 %)
a The denominator for this result is the 12 systematic reviews which did not contain a meta-analysis
b Ex.: “sensitivities of studies varied widely”
Table 3 Measures of statistical heterogeneity per type of accuracy estimator (n=53)
Cochran’s Q test n(%) I2 n(%) τ2 n(%) Any test or measurement n(%)
Sensitivity and/or specificity 22 (42 %) 24 (45 %) 4 (8 %) 31 (58 %)
Predictive values 3 (6 %) 3 (6 %) 1 (2 %) 4 (8 %)
DOR 9 (17 %) 10 (19 %) 1 (2 %) 13 (25 %)
Accuracy 2 (4 %) 2 (4 %) 1 (2 %) 3 (6 %)
Likelihood Ratio 9 (17 %) 5 (9 %) 3 (6 %) 10 (19 %)
Any parameter 31 (58 %) 26 (49 %) 7 (13 %)
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mentioned one cut-off for I2; if I2 was >50 %, they con-
sidered there to be statistical heterogeneity. Of the 7 re-
views that relied on both Cochran’s Q test and the I2, all
used the cutoff of >50 % for I2, and for the p-value for
the Q test; 4 used <.05 and 3 used <0.1.
The between-study variance, τ2, which comes from a
random effects model, was reported in 7 reviews (13 %).
In 6 of these reviews, the τ2 was from a univariate ana-
lysis (in these studies no bivariate analysis was per-
formed), and in one study the τ2s came from a bivariate
random effects model. Prediction regions were only re-
ported in 3 reviews (6 %), of which 1 study reported pre-
diction intervals for sensitivity and specificity separately
and 2 drew prediction ellipses in ROC space.
Threshold effects were assessed as a source of variabil-
ity in 20 meta-analyses; 15 looked into implicit variations
of the index test (e.g., a higher vs. lower resolution im-
aging test) and 7 investigated explicit differences (e.g.,
different cut-off points).
Influence of variability on analysis decisions
Authors reported that the results of investigation of vari-
ability would guide choices in the analysis. Sixteen
(32 %) said that they would use a random effects model
if there was high variability, but otherwise use a fixed ef-
fect model. Ten of these 16 provided a definition for
high variability. Four (8 %) said that they would only in-
vestigate sources of variability if there was high variabil-
ity, of which all but one defined high variability.
Incorporation of the results about variability in
concluding remarks
Differences were found in the importance placed on the
results of the quantification of variability. We considered
articles reporting on the magnitude of the variability in
estimates either in the abstract or in the discussion and/
or conclusion section (hereafter referred to as the con-
clusions) to have put a high importance on it. More than
half of the reviews mentioned something about it in the
conclusions section (n=29; 55 %), while about a third
mentioned it in the abstract (n=15; 28 %).
Several articles vaguely addressed the amount of vari-
ability (e.g., “the sensitivity in studies varied widely”), 17
in the conclusions (32 %) and 10 in the abstract (19 %).
Four reviews (8 %) reported a variability measure in the
abstract. A relatively large proportion mentioned that
high variability precluded them from making firm con-
clusions or reported that it was a study limitation: 13 in
the conclusions (25 %) and 2 also in the abstract (4 %).
On the other hand, a few reviews mentioned that despite
the variability in results, they were still able to make
conclusions: 7 in the conclusions (13 %) and 3 also in
the abstract (6 %). Two reviews reported (in either the
conclusions or the abstract) that their analysis revealed
no relevant variability in results.
Discussion
Key findings of this review
We found that more than half of the meta-analyses of
diagnostic accuracy studies tested for statistical hetero-
geneity using Cochran’s Q test (n=28, 53 %) or quanti-
fied it using I2 (n=31, 58 %). They did this for univariate
accuracy measures: either sensitivity and specificity sep-
arately, or the DOR. Although the DOR may be more
homogenous across studies because opposite changes in
sensitivity and specificity may get cancelled out, it is crit-
ical to detect and report these opposite changes when
evaluating the clinical use of a test as the consequences
of false-positive findings (specificity) and false negative
findings (sensitivity) are hardly ever the same. Only
about one third (n=18, 34 %) of the meta-analyses per-
formed a bivariate random effects model. Of these re-
views, only 1 reported τ2, and only 2 reviews drew
prediction ellipses in ROC space.
While most reviews made use of univariate statistics,
such as Cochran’s Q test (chi-square test) and I2, the use
of these statistics should be at least be questioned, if not
discouraged, as they cannot separate out variability due
to the threshold effect [3]. A bivariate analog to the I2
has recently been developed, however research and guid-
ance on its use in reviews on diagnostic tests is needed
[15, 16]. The recommended hierarchal bivariate models
provide insight into variability beyond that which can be
explained by the threshold effect. In particular, the bi-
variate random effects model enables the calculation of
the conditional between-study variances (i.e., the vari-
ance in specificity at a fixed value of sensitivity and vice
versa). When there is a threshold effect (i.e., correlation),
the conditional between-study variances will be smaller
than the between-study variances from two separate uni-
variate analyses of sensitivity and specificity.
Only about one third of the meta-analyses in this re-
view performed the widely recommended analysis
method of choice, a bivariate random effects model or
the hierarchical summary ROC approach [3, 11]. There
are situations when it is not possible to use such a
model, such as when there are very few primary studies,
as well as situations in which researchers may only be
interested in one accuracy measure. However, the low
percentage of meta-analyses using a hierarchical bivari-
ate random effects model argues for the need for more
guidance on the implementation and interpretation of
such models.
There is room for improvement in the way that vari-
ability is quantified and reported in meta-analyses of
diagnostic studies. Although a large portion of the quan-
tification of variability is currently subjective because
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methods for quantification in reviews of studies on diag-
nostic test accuracy are under development, defining
what one considers to be a significant amount of vari-
ability and reporting the results of the quantification of
variability enhances the readers the ability to interpret
the results. Review authors should also offer explana-
tions of what these metrics mean and what the practical
implications may be of the amount of variability
observed.
Comparison with other literature
As the field of meta-analyses is rapidly developing, it is
difficult to compare our findings directly to those from
existing meta-epidemiological research on reviews of
diagnostic studies [1, 13]. The I2 was introduced in 2002
and the bivariate random effects model for sensitivity
and specificity was introduced in 2005 [9]. Compared to
prior reviews, our review found that the use of Cochran’s
Q test remains high and that the I2 is now also com-
monly used alongside it. While the use of bivariate ran-
dom effects meta-analyses is increasing [2], our review
found that the between study variances (τ2s) that are es-
timated from this approach are not always reported and
the prediction regions are rarely reported.
Strengths and weaknesses of this review
While our review contains a relatively small set of sys-
tematic reviews published within a short timeframe, we
do not think that this is a major weakness. As there have
been many advances in reviews on diagnostic tests since
the existing reviews on this topic were performed, our
review, which contains a recent set of publications, is
still highly relevant for current practice. Additionally,
while our search strategy could have missed some rele-
vant reviews, we think that the representative sample of
over 50 reviews was enough to obtain theoretical satur-
ation. In other words, that including more reviews would
not have significantly changed our conclusions [17]. A
limitation of this review, which is true for any review on
methodology, is that we observed only what authors re-
ported having done, not what they actually did.
Initial guidance
While a high level of importance was generally given to
the quantification of variability, as can be seen by the
high frequency with which it was mentioned in the
prominent sections of the paper, there is room for im-
provement. There is a need for formal guidance on the
quantification of variability in meta-analyses of diagnos-
tic studies. Below we provide an outline of what such
guidance may look like, focusing on the bivariate ran-
dom effects model framework (Fig. 1).
I. Visualize total variability in sensitivity and specificity
by presenting the data in forest and ROC plots,
preferably showing the precision of the estimates
using crosshairs or by varying the size of the points.
II. Judge whether there is more variability in sensitivity
and specificity than could be expected due to chance
alone through visual inspection of the data. While
Cochran’s Q test facilitates this judgment in meta-
analyses of univariate outcomes, no such analogue
has been developed for the bivariate diagnostic
setting to our knowledge. Such test(s) could detect
beyond-chance variability around a summary point
or around a curve in ROC space. For now, visualizing
results in ROC space may help determine which
hierarchical bivariate random effects model to use
(the bivariate random effects model which focuses on
estimating a summary point or the HSROC which
focuses on estimating a summary curve). Additionally,
if the hierarchical bivariate model fails to converge or
provides unreliable estimates (as is often the case
when there are few studies or sparse data due to
extreme sensitivity or specificity), observation of the
data on the plot can guide decisions on how to
simplify the analyses [18].
III. Measure total between-study variability in sensitiv-
ity and in specificity (τ2s) by fitting a (bivariate) ran-
dom effects model. Interpretation of the τ2s can be
facilitated by presenting confidence and prediction
intervals [19]. If a bivariate random effects model
fails, two separate univariate random effects models
should be considered. The τ2s from these univariate
random effects models express the amount of
variability that cannot be explained by chance,
assuming no correlation between sensitivity and
specificity. In univariate analyses, I2 provides a
measure of variability. While an analog has been
developed for the bivariate setting, more research
and guidance is needed on how to implement it
reviews on diagnostic tests is needed [15, 16].
IV. Attribute some of the between study-variability to
the threshold effect by fitting a bivariate random
effects model. The conditional between-study
variability for sensitivity and for specificity (the
conditional τ2s) is the variability beyond both chance
and the threshold effect. It can be calculated using
the covariance and the total between-study variances.
Both confidence and prediction ellipses should be
provided to assist interpretation.
V. Explore what might be causing the systematic
differences in accuracy estimates between the
primary studies [20]. Again, a hierarchical bivariate
random effects model is a sound and flexible
approach for investigating the impact of study
characteristics on sensitivity or specificity or both.
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The quantification of variability is not simply a
methodological exercise; variability in results can have
implications for clinical practice. While consistency of
results across studies strengthens overall findings, in-
consistency can complicate interpretations. The more
variability beyond chance that has not been explained,
the more difficult it is to come to strong conclusions
about the clinical implications of the findings of the
meta-analysis [7]. Investigations of variability identify
important differences in test performance across pa-
tient subgroups, variations of the test(s) under study,
or study designs. The more variability that can be ex-
plained by sample size, threshold effects, or study
characteristics, the more confidence can be placed in
the results.
Ideally, variability in results can best be addressed in
individual participant data meta-analyses. Unfortunately,
however, there are many barriers to accessing and com-
bining the primary data to perform such analyses.
Conclusion
In conclusion, approaches to assessing variability in esti-
mates of accuracy varied widely between diagnostic test
accuracy reviews and there is room for improvement. We
have provided initial guidance in this area, complemented
by an overview of the currently available approaches.
Total variability
Assessing variability in results for bivariate outcomes
I. Visualizetotal variability
II. Judge whether there is more 
variability in sensitivity and
specificity than can be expected 
due to chance (sampling error) 
alone
III. Measure the total between -
study variability
IV. Attribute some of the between-
study variability to the threshold 
effect
V. Explore what study features 
might explain some of the 
variability
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Fig. 1 Steps for assessing variability in reviews of diagnostic tests when there are two potentially correlated outcomes of interest, sensitivity and specificity
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